A European Consensus on the Consistent Use of the Term “Keratinocyte Cancer”

Keratinocyte-derived skin cancers comprise basal cell carcinoma, squamous cell carcinoma, its precursor actinic keratosis, and Bowen's disease. Historically, this group of neoplasms has been subsumed under the term non-melanoma skin cancer. However, the term non-melanoma skin cancer can be misleading and lacks precision. Therefore, more precise and reasonable terminology, valuing the relevance of keratinocyte-derived cancer, appears pertinent to meet its clinical and scientific significance. A group of experienced dermato-oncologists initiated a consensus approach to promote the use of the term "keratinocyte cancer" instead of "non-melanoma skin cancer" when referring to carcinomas and their precursors that are derived from keratinocytes. The vote among members of the consensus group indicated unanimous agreement on the consistent use of the term "keratinocyte cancer" instead of "non-melanoma skin cancer". International delegates also voted in favour of the revised terminology. The more precise and, by means of etiopathogenesis, correct term "keratinocyte cancer" should be consistently used for malignancies originated from keratinocytes. This is expected to have a positive impact on patient-physician communication and gives better justice to this important group of keratinocyte-derived cancers.

Authors

Institutions

Publication Details

Journal
Acta Dermato Venereologica
Published
2024-08-05
DOI
https://doi.org/10.2340/actadv.v104.40601
Citations
1
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A European Consensus on the Consistent Use of the Term “Keratinocyte Cancer”

C.A. Morton, Elena Sotiriou, Yolanda Gilaberte, Thomas Dirschka et al.
1 citations
Acta Dermato Venereologica
Nonmelanoma Skin Cancer Studies
0.39
article

A European Consensus on the Consistent Use of the Term “Keratinocyte Cancer”

C.A. Morton, Elena Sotiriou, Yolanda Gilaberte, Thomas Dirschka, Stine Regin Wiegell, Hans Christian Wulf, Nicole Basset‐Séguin, Günther F.L. Hofbauer, Merete Hædersdal, Wolfgang G. Philipp‐Dormston, Piergiacomo Calzavara-Pinton, Lasse R. Braathen, R.‐M. Szeimies
article en
1 citations

Abstract

Keratinocyte-derived skin cancers comprise basal cell carcinoma, squamous cell carcinoma, its precursor actinic keratosis, and Bowen's disease. Historically, this group of neoplasms has been subsumed under the term non-melanoma skin cancer. However, the term non-melanoma skin cancer can be misleading and lacks precision. Therefore, more precise and reasonable terminology, valuing the relevance of keratinocyte-derived cancer, appears pertinent to meet its clinical and scientific significance. A group of experienced dermato-oncologists initiated a consensus approach to promote the use of the term "keratinocyte cancer" instead of "non-melanoma skin cancer" when referring to carcinomas and their precursors that are derived from keratinocytes. The vote among members of the consensus group indicated unanimous agreement on the consistent use of the term "keratinocyte cancer" instead of "non-melanoma skin cancer". International delegates also voted in favour of the revised terminology. The more precise and, by means of etiopathogenesis, correct term "keratinocyte cancer" should be consistently used for malignancies originated from keratinocytes. This is expected to have a positive impact on patient-physician communication and gives better justice to this important group of keratinocyte-derived cancers.

Acta Dermato VenereologicaVol. 104
University of Copenhagen (DK), Witten/Herdecke University (DE), University of Wuppertal (DE), University of Zurich (CH), Université Paris Cité (FR), Aristotle University of Thessaloniki (GR), Universidad de Zaragoza (ES), Frederiksberg Hospital (DK), Bispebjerg Hospital (DK), Klinikum Vest (DE), University Hospital of Zurich (CH), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Knappschaftskrankenhaus Recklinghausen (DE), Instituto de Investigación Sanitaria Aragón (ES), Hôpital Saint-Louis (FR), University of Brescia (IT)
Amgen, Sanofi, Les Laboratories Pierre Fabre, Incyte, Galderma, Sun Pharma, LEO Pharma
Good health and well-being
Openalex Percentile: Top 36%
Nonmelanoma Skin Cancer Studies
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.